These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37210309)

  • 1. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
    Salmanton-García J; Wipfler P; Valle-Simón P; Merakou C; Kopsidas I; Bethe U; Steinbach A; Spivak O; Součková L; Mendonça MA; Koniordou M; Hellemans M; Frías-Iniesta J; Davis RJ; Barta I; Azzini AM; Askling HH; Argyropoulos CD; Álvarez-Barco E; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Flisiak R; Husa P; Jancoriene L; Koscalova A; Launay O; Lundgren J; Mallon P; Marques L; Nauclér P; Ochando J; Pana ZD; Tacconelli E; Tóth K; Trelle S; van Damme P; Zaoutis TE; Zeitlinger M; Albus K; Stewart FA; Hofstraat SHI; Bruijning-Verhagen P; Cornely OA;
    Vaccine; 2023 Jun; 41(26):3915-3922. PubMed ID: 37210309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
    Salmanton-García J; Stewart FA; Heringer S; Koniordou M; Álvarez-Barco E; Argyropoulos CD; Themistocleous SC; Valle-Simón P; Spivak O; Součková L; Merakou C; Amélia Mendonça M; Joanna Davis R; Maria Azzini A; Askling HH; Vene S; Van Damme P; Steinbach A; Shiamakkides G; Seidel D; Olesen OF; Noula E; Macken A; Luís C; Leckler J; Launay O; Isitt C; Hellemans M; Frías-Iniesta J; Di Marzo R; Carcas AJ; Boustras G; Borobia AM; Barta I; Albus K; Akova M; Ochando J; Cohen-Kandli M; Jane Cox R; Husa P; Jancoriene L; Mallon P; Marques L; Mellinghoff SC; Nauclér P; Tacconelli E; Tóth K; Zaoutis TE; Zeitlinger M; Cornely OA; Pana ZD;
    Vaccine; 2022 Jul; 40(31):4090-4097. PubMed ID: 35659449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.
    Argyropoulos CD; Leckler J; Salmanton-García J; Constantinou M; Alexandrou A; Themistocleous S; Noula E; Shiamakkides G; Nearchou A; Stewart FA; Albus K; Koniordou M; Kopsidas I; Spivak O; Hellemans M; Hendrickx G; Davis RJ; Azzini AM; Simon PV; Carcas-Sansuan AJ; Askling HH; Vene S; Prellezo JB; Álvarez-Barco E; Macken AJ; Di Marzo R; Luís C; Olesen OF; Frias Iniesta JA; Barta I; Tóth K; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Součková L; Husa P; Jancoriene L; Launay O; Lundgren J; Mallon P; Armeftis C; Marques L; Naucler P; Ochando J; Tacconelli E; van Damme P; Zaoutis T; Hofstraat S; Bruijning-Verhagen P; Zeitlinger M; Cornely OA; Pana ZD
    JMIR Public Health Surveill; 2023 Apr; 9():e44491. PubMed ID: 36878478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.
    Themistocleous S; Argyropoulos CD; Vogazianos P; Shiamakkides G; Noula E; Nearchou A; Yiallouris A; Filippou C; Stewart FA; Koniordou M; Kopsidas I; Askling HH; Vene S; Gagneux-Brunon A; Prellezo JB; Álvarez-Barco E; Salmanton-García J; Leckler J; Macken AJ; Davis RJ; Azzini AM; Armeftis C; Hellemans M; Di Marzo R; Luis C; Olesen OF; Valdenmaiier O; Jakobsen SF; Nauclér P; Launay O; Mallon P; Ochando J; van Damme P; Tacconelli E; Zaoutis T; Cornely OA; Pana ZD
    JMIR Public Health Surveill; 2024 Apr; 10():e47241. PubMed ID: 38573762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics.
    Salmanton-García J; Wipfler P; Leckler J; Nauclér P; Mallon PW; Bruijning-Verhagen PCJL; Schmitt HJ; Bethe U; Olesen OF; Stewart FA; Albus K; Cornely OA;
    Travel Med Infect Dis; 2024; 57():102676. PubMed ID: 38061408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
    Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA
    Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.
    Poulimeneas D; Koniordou M; Kousi D; Merakou C; Kopsidas I; Tsopela GC; Argyropoulos CD; Themistocleous SC; Shiamakkides G; Constantinou M; Alexandrou A; Noula E; Nearchou A; Salmanton-García J; Stewart FA; Heringer S; Albus K; Álvarez-Barco E; Macken A; Di Marzo R; Luis C; Valle-Simón P; Askling HH; Hellemans M; Spivak O; Davis RJ; Azzini AM; Barta I; Součková L; Jancoriene L; Akova M; Mallon PWG; Olesen OF; Frias-Iniesta J; van Damme P; Tóth K; Cohen-Kandli M; Cox RJ; Husa P; Nauclér P; Marques L; Ochando J; Tacconelli E; Zeitlinger M; Cornely OA; Pana ZD; Zaoutis TE;
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Education pathways and key tasks for research nurses in Europe, results from a VACCELERATE online survey.
    Salmanton-García J; Stewart FA; Wipfler P; Hofstraat SHI; Bruijning-Verhagen P; Cornely OA
    Nurse Educ Pract; 2024 May; 77():103953. PubMed ID: 38598884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
    Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
    Mena Lora AJ; Long JE; Huang Y; Baden LR; El Sahly HM; Follmann D; Goepfert P; Gray G; Grinsztejn B; Kotloff K; Rouphael N; Sobieszczyk M; Walsh SR; Andriesen J; Shah KA; Zhang Y; Gilbert P; Janes H; Gay CL; Falsey AR; Tripp RL; Gorman RL; Tong T; Marovich M; Neuzil K; Corey L; Kublin JG;
    JAMA Netw Open; 2023 Jan; 6(1):e2251974. PubMed ID: 36689221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping time use in clinical trials for vaccines against emerging infectious diseases.
    Mandi H; Yimer SA; Norheim G
    Clin Trials; 2021 Jun; 18(3):286-294. PubMed ID: 33653146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.
    Rubio-San-Simón A; André N; Cefalo MG; Aerts I; Castañeda A; Benezech S; Makin G; van Eijkelenburg N; Nysom K; Marshall L; Gambart M; Hladun R; Rossig C; Bergamaschi L; Fagioli F; Carpenter B; Ducassou S; Owens C; Øra I; Ribelles AJ; De Wilde B; Guerra-García P; Strullu M; Rizzari C; Ek T; Hettmer S; Gerber NU; Rawlings C; Diezi M; Palmu S; Ruggiero A; Verdú J; de Rojas T; Vassal G; Geoerger B; Moreno L; Bautista F
    Eur J Cancer; 2020 Dec; 141():82-91. PubMed ID: 33129040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.